| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:KP 10614
CAS:130273-99-3
Purity:0 Package:25mg/RMB 37000;50mg/RMB 49800;100mg/RMB 65500
|
|
| | 4,5,18,18,19,19-Hexadehydro-16,20-dimethyl-delta 6(9a)-9(O)-methano-pr ostaglandin I1 Basic information |
| Product Name: | 4,5,18,18,19,19-Hexadehydro-16,20-dimethyl-delta 6(9a)-9(O)-methano-pr ostaglandin I1 | | Synonyms: | 4,5,18,18,19,19-Hexadehydro-16,20-dimethyl-delta 6(9a)-9(O)-methano-pr ostaglandin I1;KP 10614;(4Z)-5-[[(3aS)-3,3aβ,4,5,6,6aβ-Hexahydro-5α-hydroxy-4β-[(1E,3S,4S)-3-hydroxy-4-methyl-1-nonen-6-ynyl]pentalen]-2-yl]-4-pentenoic acid | | CAS: | 130273-99-3 | | MF: | C23H32O4 | | MW: | 372.49778 | | EINECS: | | | Product Categories: | | | Mol File: | 130273-99-3.mol |  |
| | 4,5,18,18,19,19-Hexadehydro-16,20-dimethyl-delta 6(9a)-9(O)-methano-pr ostaglandin I1 Chemical Properties |
| | 4,5,18,18,19,19-Hexadehydro-16,20-dimethyl-delta 6(9a)-9(O)-methano-pr ostaglandin I1 Usage And Synthesis |
| Description | KP 10614 is a new prostacyclin analog that inhibits platelet-polymorphonuclear leukocyte interaction. |
| | 4,5,18,18,19,19-Hexadehydro-16,20-dimethyl-delta 6(9a)-9(O)-methano-pr ostaglandin I1 Preparation Products And Raw materials |
|